Close
  Indian J Med Microbiol
 

Figure 2: Flow-chart summarizing when mutation analysis is recommended in chronic myeloid leukaemia-chronic phase patients treated with imatinib first-line. (CP - Chronic phase; CHR - Complete hematologic response; PCyR - Partial cytogenetic response; CCyR - Complete cytogenetic response; MMR - Major molecular response; CCA/Ph + - Clonal chromosomal abnormalities in the Ph + clone

Figure 2: Flow-chart summarizing when mutation analysis is recommended in chronic myeloid leukaemia-chronic phase patients treated with imatinib first-line. (CP - Chronic phase; CHR - Complete hematologic response; PCyR - Partial cytogenetic response; CCyR - Complete cytogenetic response; MMR - Major molecular response; CCA/Ph + - Clonal chromosomal abnormalities in the Ph + clone